Yaming Su, Ph.D.

Affiliations: 
2006 Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Pharmacology, Oncology
Google:
"Yaming Su"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Patrick J. Sinko grad student 2006 Rutgers, New Brunswick
 (The role of efflux transporters in the pharmacokinetics and pharmacodynamics of anti-cancer drugs.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Su YY, Cui HJ, Li KC. (2016) Parameter estimation of varying coefficients structural EV model with time series Acta Mathematica Sinica, English Series. 1-13
Su Y, Hu P, Lee SH, et al. (2007) Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, SociéTé Canadienne Des Sciences Pharmaceutiques. 10: 519-36
Su Y, Zhang X, Sinko PJ. (2007) Exploitation of drug-induced Bcl-2 overexpression for restoring normal apoptosis function: a promising new approach to the treatment of multidrug resistant cancer. Cancer Letters. 253: 115-23
Su Y, Lee SH, Sinko PJ. (2006) Inhibition of efflux transporter ABCG2/BCRP does not restore mitoxantrone sensitivity in irinotecan-selected human leukemia CPT-K5 cells: evidence for multifactorial multidrug resistance. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 29: 102-10
Su Y, Sinko PJ. (2006) Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it? Expert Opinion On Drug Delivery. 3: 419-35
Zhang X, Wan L, Pooyan S, et al. (2004) Quantitative assessment of the cell penetrating properties of RI-Tat-9: evidence for a cell type-specific barrier at the plasma membrane of epithelial cells. Molecular Pharmaceutics. 1: 145-55
Su Y, Zhang X, Sinko PJ. (2004) Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells. Molecular Pharmaceutics. 1: 49-56
Su Y, Lee SH, Sinko PJ. (2004) Practical aspects of transporter model systems: a case study involving SQV. Drug Metabolism Reviews. 36: 377-89
See more...